chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FELT LIKE CRAP; TIGHTNESS IN CHEST; COLD HANDS; BURNING SENSATION IN BODY; INSOMNIA; DRY MOUTH; FREQUENT URINATION; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 21-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced burning sensation in body. On 21-MAR-2021, the subject experienced insomnia. On 21-MAR-2021, the subject experienced dry mouth. On 21-MAR-2021, the subject experienced frequent urination. On 21-MAR-2021, the subject experienced chills. On 21-MAR-2021, the subject experienced headache. On 22-MAR-2021, the subject experienced tightness in chest. On 22-MAR-2021, the subject experienced cold hands. On an unspecified date, the subject experienced felt like crap. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cold hands, and the outcome of burning sensation in body, tightness in chest, insomnia, chills, headache, dry mouth, frequent urination and felt like crap was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per the standard procedure as the case is assessed as non-serious.
One day after the vaccination with Anthrax #4 pt developed a red, swollen, raised, flat, tender and warm area 2 x 6 cm. Pt advised to treat with Motrin and warm compressions per Dr of the Healthcare Center. He also requested future Anthrax vaccinations be give IM as opposed to SC.
Back pain; Pain got worst to the rest of the arm; (Pain) to the rest of the body/Mild localized pain/at night got horrible pain/got spots of pain during the night that woke the patient up; Fever- 99F; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain got worst to the rest of the arm), MYALGIA ((Pain) to the rest of the body/Mild localized pain/at night got horrible pain/got spots of pain during the night that woke the patient up) and PYREXIA (Fever- 99F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A, 016M20A and 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Spinal stenosis (Degenerative spinal stenosis). Concomitant products included LORAZEPAM for Insomnia, ROSUVASTATIN and FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Sep-2021, the patient experienced BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain got worst to the rest of the arm), MYALGIA ((Pain) to the rest of the body/Mild localized pain/at night got horrible pain/got spots of pain during the night that woke the patient up) and PYREXIA (Fever- 99F). At the time of the report, BACK PAIN (Back pain), PAIN IN EXTREMITY (Pain got worst to the rest of the arm) and MYALGIA ((Pain) to the rest of the body/Mild localized pain/at night got horrible pain/got spots of pain during the night that woke the patient up) was resolving and PYREXIA (Fever- 99F) outcome was unknown.            No Treatment medications were reported.   This case was linked to MOD-2021-338672 (Patient Link).
Since the second Covid vaccine injection I have had breathing problems for months and am tired all the time whereas before I was taking regular 2 mile walks with my walker and able to breathe fine even uphill. Now it appears I will be undergoing catheterization  due to the effects of this vaccine.
PERSON HAD BEEN AT LTCF PRIOR AND AT TIME OF DEATH; LIMITED NOTES AVAILABLE.
Breakthrough case admission after three vaccines  Moderna 1/29/21 Lot# 007M20A;  Moderna 3/1/21 Lot# 010A21A; Moderna 11/29/21 Lot# 013F21A
Pink eye; Eye irritation right eye; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 24Apr2021 at 10:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two prior to the vaccination. The patient previously took aspirin (MANUFACTURE UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 26Apr2021 at 07:00, the patient experienced pink eye and eye irritation right eye. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pink eye and eye irritation right eye was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Large red, swollen, painful spot on arm, 4" in diameter and lasting 6 days.
The skin at the injection site feels warmer than the skin around; swollen; Feeling tender; small red area there, larger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (The skin at the injection site feels warmer than the skin around), VACCINATION SITE ERYTHEMA (small red area there, larger), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (Feeling tender) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LOSARTAN and VITAMINS NOS for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (small red area there, larger). On 09-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (Feeling tender). On an unknown date, the patient experienced VACCINATION SITE WARMTH (The skin at the injection site feels warmer than the skin around). At the time of the report, VACCINATION SITE WARMTH (The skin at the injection site feels warmer than the skin around), VACCINATION SITE ERYTHEMA (small red area there, larger), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (Feeling tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications includes unspecified body lotion on injection site . Reportedly the patient's body temperature was 97.8.    Most recent FOLLOW-UP information incorporated above includes: On 26-Mar-2021: Initial additional : Included no new information.
We were under the impression we were administering the Pfizer Bivalent COVID booster but we adminsitered the Pfizer Monovalent COVID vaccine in error. Patient was made aware of the error and given CDC guidance on how to proceed.
Tingling sensation on entire right side of face; Muscle weakness in cheeks/ right side feels very weak; Muscle weakness in tongue; Slight drooling; Impairing speech ability; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Jun2021 at 10:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included morphea. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN); for an unknown indication from an unknown date and unknown if ongoing. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23May2021 at 12:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Jun2021, the patient experienced tingling sensation on entire right side of face, muscle weakness in cheeks and tongue which resulted in drooling. The patient reported that she was able to smile but the right side felt very weak. The patient also experienced impaired speech ability. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling sensation on entire right side of face, muscle weakness in cheeks and tongue which resulted in drooling, right side felt very weak and impaired speech ability was not resolved at the time of this report.   The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.
Pt was administered booster dose of covid-19 Moderna vaccine too early. Earliest due was 3/6/22
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse) from Regulatory Authority. The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Oct2021 at 16:00 as dose 3 (booster), single (Lot number: FF25B9) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Latex" (unspecified if ongoing), notes: known allergies: Latex. The patient's concomitant medications were not reported. Past drug history included: Ancef, reaction(s): "known allergies: Ancef", notes: known allergies: Ancef. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course- The patient took Paxlovid and felt better 4-8 hours after. The symptom onset 15. The patient was very sick from COVID and  felt the Paxlovid helped but she still had stuffy nose fatigues then on 19 the patient was done with medication and on 25 started to have a lot of congestion and runny nose and feel sick again but more of a head cold.  The patient receive other vaccines within 4 weeks prior to the COVID vaccine. There was list of other medications Ibroprofen the patient received within 2 weeks of vaccination. Device Date: 28May2022  No follow-up attempts are needed. No further information is expected.
Woke up crying and gasping for air 2 hours post vaccine administration; hives around injection site and all over the back appeared 24 hours post vaccine administration.
I have developed Tinnitus ? a constant ringing in the ear that has been going on 24/7 since around 2 months after the second vaccine.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 14-OCT-2012 14:26, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Fever; chills/rigors; Severe myalgia; Nausea; vomiting; Severe headache; This is a spontaneous report from a contactable physician (patient). A 49-year-old female patient (no pregnancy) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), with first dose (lot number: ACEK5703) at 16:00 on 16Dec2020 and with second dose (lot number: EK9231) at 16:00 on 06Jan2021, both intramuscularly at site of left arm at single dose for COVID-19 immunization. Medical history reported none. The patient's concomitant medications were not reported. The patient experienced fever, chills, rigors, severe myalgia, nausea, vomiting, and severe headache at 01:00 AM on 07Jan2021. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No list of any other medications the patient received within 2 weeks of vaccination. The patient received treatment of paracetamol (TYLENOL) for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. No allergies to medications, food, or other products. This case was identified as non-serious by reporter. The outcome of events was recovered in Jan2021.
2 days after vaccine he had lower lip swelling. Treated at private hospital with MEDROL dose pack. Today Feb 7 he was again treated with 60mg po of prednisone, 40mg po of PEPCID, he deferred the diphenhydramine.
The pt experienced irritability and fussiness at night, won't sleep lying down. Up several times at night.
Clonic jerks of the right arm. Focal Seizure, left and right face twitching. Second event of staring and leftward head and eye deviation for 1-2 minutes.
I was away visiting my daughter who was not feeling well, although she tested negative for COVID-19 I came home. Once I got home was extremely fatigued, felt very unwell, I took a home COVID-19 test that did come back positive. I called my doctor to have a telehealth visit. We discussed my symptoms, she prescribed the Paxlovid that I was able to start that evening. It did take ten days for me to feel better and test negative.
Confirmed Breakthrough Case   COVID-19 (Moderna) 1 Moderna 007B21A   COVID-19 (Moderna) 2 Moderna 006C21A   COVID-19 (Moderna) 3 Moderna 069F21A
I started having hearing loss, ear fullness and tinnitus a few weeks after my second dose of Moderna in 2/21.   These symptoms improved with time, but after my booster dose of Moderna (11/21)  I experienced a flare in symptoms and they returned to their original form, including the hearing loss and tinnitus.
Very tired day after vaccination.. Went to sleep 3 times during that day. Better the following day and fine by the next.
Called today complaining of arm being very sore since receiving vaccine; throbs at night and keeps him awake.
Patient was determined to be healthy at her 1-year check-up, given the HepB vaccine; 3 days later, on Friday, she started presenting with flu-like symptoms, continued on Saturday, Sunday,  and finally spiked a sudden fever on Sunday evening and had a febrize seizure.  Local fire dept/EMS responders transported her to emergency.
lymphadenopathy; joint pain; muscle pain; chills; fatigued; sore, pain at site normal for vaccine admin; This is a spontaneous report from a contactable pharmacist. An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EJ1685) intramuscularly on 17Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 17Dec2020 21:00, the patient was fatigued and had sore pain at the site of vaccine administration. On 18Dec2020, the patient experienced joint pain, muscle pain and chills. On 19Dec2020, the patient developed lymphadenopathy. The events were reported as non-serious. Outcome of events recovered on an unspecified date on Dec2020.
Unable to move arm or lift. It is very painful. No redness or swelling to the injection site.
Severe menstrual cramping for 3 days before the menstrual cycle; Bad anxiety attack; Soreness of the Left arm/Soreness got worse during the night; Several headaches; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness of the Left arm/Soreness got worse during the night), HEADACHE (Several headaches), CHILLS (Chills), NAUSEA (Nausea) and ANXIETY (Bad anxiety attack) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C71A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness of the Left arm/Soreness got worse during the night), HEADACHE (Several headaches), CHILLS (Chills), NAUSEA (Nausea) and ANXIETY (Bad anxiety attack). On an unknown date, the patient experienced PREMENSTRUAL PAIN (Severe menstrual cramping for 3 days before the menstrual cycle). At the time of the report, VACCINATION SITE PAIN (Soreness of the Left arm/Soreness got worse during the night), HEADACHE (Several headaches), CHILLS (Chills), NAUSEA (Nausea), ANXIETY (Bad anxiety attack) and PREMENSTRUAL PAIN (Severe menstrual cramping for 3 days before the menstrual cycle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated she is not sure about receiving the second dose as scheduled on 4th June 2021, patient  wants to know whether she has to restart the vaccination series if she did not receive the vaccine on the scheduled date. No Treatment and Concomitant medications were reported
doesn't feel well at all today; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills). At the time of the report, MALAISE (doesn't feel well at all today), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            No concomitant medications and treatment information were reported.   This case was linked to MOD-2021-024388 (Patient Link).
Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 21-JAN-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ML (lot # L010598, excursion date 06-AUG-2016, route unknown). This specified lot number vaccine was exposed to temperature excursion sixteen times. The total cumulative excursion time (hour) and lowest recorded temperature (Fahrenheit degree) for each time were as below: (216, 29.3); (144, 34.2); (52, 33.1); (72, 32.9); (144, 32.4); (100, 34.5); (28, 30); (24, 34.3); (104, 29.1); (48, 34.9); (26, 31.1); (24, 34.8), (64, 34); (56, 33.4); (24, 34.7); (100, 33.6). The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning a 60 year old male who on an unspecified date was vaccinated with a single dose of ZOSTAVAX. On approximately 20-JUN-2008 the patient developed zoster. Zoster was improved after stopping therapy  with ZOSTAVAX. No product quality complaint was involved. No further information is available.
Patient came to the hospital feeling lethargic.  Patient has not had significant shortness of breath, x-ray showed bibasilar and perihilar pneumonia.  Patient tested positive for COVID-19 1/26/22.  Discharged 1/29/22. Moderna 5/17/21 & 6/18/21
Swelling in lower right forearm, warm/hot to the touch, red, no tenderness. Swelling started in right tricep area with redness.
Developed pruritic annular raised erythematous with central clearing rash at injection site about 10 days after injection received.
first 2 days ran temperature in the 101-102 degree range, UTI and kidney infection, migraine headache, tingling and numbness in arms/hands and legs/feet as if the extremities had fallen asleep, decreased ability to walk
2/14/08 102 degree fever @ 900pm/gave Tylenol. 2/15/08 100 degree fever @ 400am/gave Tylenol.  2/15/08 100.1 degree fever @ 925am/gave Tylenol.
Following consultation with the patient?s pediatrician, the patient?s mother requested that he be given a second dose of Moderna. Medical Director, Dr. consulted with Health Department Medical Director, Dr. Given that the mother discussed this with her son?s pediatrician and made a shared, informed decision, Dr. approved administration of the Moderna vaccine.
I received the Janssen vaccine on March 13.  By the next weekend, I had what I thought was a spider bite on the inside of my left thigh.  That "bite" got worse--bigger, hot to the touch, and then red.  On the weekend of the 27-28 of March, it was red, raised and very painful even when not touched.     I called my family doctor on Monday morning, the 29th of March, and I was sent to the Emergency Room, where I was diagnosed with a 7cm thrombosis in my left greater saphenous vein, which is treated the same as a DVT.    I was treated first with Lovenox injections, then Eliquis 10 mg 2x daily, now 5 mg 2x daily.    The blood clot is still painful to the touch.
This spontaneous report as received from a other health professional refers to a 15 years old female patient with asthma. The patient was vaccinated with lot # (669796/0840AA) dose 1 GARDASIL, right deltoid and with lot # (669842/0931AA) dose 2 VARIVAX (Merck), SC, left deltoid on 22-DEC-2011 at 15:14. Concomitant medications included HAVRIX and FLUZONE. It was reported that the patient was administered an immunization that was stored at invalid temperatures, the immunization was stored at a temperature of 32 degrees F or less. No adverse reaction occurred. This is one of several reports from the same source. Additional information is not expected.
within 5 min of giving,, pt complained of L are numbness.  Within 2-3 mins after that, pt started having dry cough that proceeded to worsen and then pt vomited 3-4 times.  Vomited what appeared to be clear and white mucus.  Pt O2 sats remained 99 to 100% on room air.  Pt BP was elevated 180/102.  Pt given 25 mg benadryl and taken to ED for evaluation.  Pt D/C from ED post eval.